Revolutions Medical collaborates on clinical applications and validation process of MRI software tools

NewsGuard 100/100 Score

Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB:RMCP), begins collaboration with H. Keith Brown, PhD, Philadelphia College of Osteopathic Medicine, on two clinical applications using their proprietary Magnetic Resonance software tools; RevDisplay, RevColor and Rev3D.  One clinical application is for the differentiation and characterization of Intracranial Hemorrhages by Color MRI Automatic Segmentation and the other is for characterization of intracranial masses by Color MRI Automatic Segmentation. 

Led by Professor of Anatomy, H. Keith Brown, PhD, these studies will be the first of their kind to examine the use of RevMed's proprietary MRI software tools to enhance diagnostic confidence in the diagnosis of tumors, cysts, and other masses and to aid in distinguishing between older blood and new blood for concussions and other head injuries.

"To be working with the pioneer of color MRI, H. Keith Brown, PhD, on a project of this importance, means a great deal to all of us here at Revolutions Medical.  We will now begin the validation process for the use of our MRI software tools through these first of many clinical applications to be delivered through our software as a service (SAS) model.  We believe this process has the potential to add tremendous value to the company as we launch our tools into the marketplace," stated Ron Wheet, CEO, Revolutions Medical. 

Source Revolutions Medical Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exploring instruments for assay development and optimization